The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 19, 2018
Filed:
Nov. 12, 2015
Applicant:
Reveragen Biopharma, Inc, Rockville, MD (US);
Inventors:
John M. McCall, Boca Grande, FL (US);
Eric Hoffman, Kensington, MD (US);
Kanneboyina Nagaraju, Columbia, MD (US);
Assignee:
ReveraGen BioPharma, Inc., Rockville, MD (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/56 (2006.01); C07J 9/00 (2006.01); A61K 31/575 (2006.01); C07J 5/00 (2006.01); A61K 31/573 (2006.01); A61K 45/06 (2006.01); C07J 7/00 (2006.01); C07J 13/00 (2006.01); C07J 21/00 (2006.01); C07J 51/00 (2006.01);
U.S. Cl.
CPC ...
C07J 9/005 (2013.01); A61K 31/573 (2013.01); A61K 31/575 (2013.01); A61K 45/06 (2013.01); C07J 5/0038 (2013.01); C07J 5/0053 (2013.01); C07J 5/0076 (2013.01); C07J 7/008 (2013.01); C07J 9/00 (2013.01); C07J 5/003 (2013.01); C07J 5/0069 (2013.01); C07J 13/005 (2013.01); C07J 21/00 (2013.01); C07J 51/00 (2013.01);
Abstract
The present invention relates to compounds and methods which may be useful as treatments of neuromuscular diseases such as muscular dystrophy, and as inhibitors of NF-κB for the treatment or prevention of muscular wasting disease, including muscular dystrophy.